Mechanisms of microvascular thrombosis in inflammation

炎症中微血管血栓形成的机制

基本信息

项目摘要

Thrombosis and inflammation (or thromboinflammation) are interrelated in a variety of illnesses including sepsis or the body’s dysregulated response to an infection, and the novel Coronavirus 2019 (COVID-19). Sepsis is typically the most common individual admission diagnosis in intensive care units in the VA system, although during certain weeks in 2020, COVID-19 was by far the leading acute medicine admission diagnosis at our VA Medical Center and others in the VA system. Despite advances in critical care medicine, sepsis and COVID-19 remain as life-threatening conditions resulting in significant morbidity, mortality, and a high economic burden in Veterans and non-Veterans worldwide. Both COVID-19 and sepsis are associated with microvascular thrombosis and coagulopathy and in both conditions, the severity of coagulopathy is associated with increased mortality rates. Thus, understanding the mechanisms of microvascular thrombosis in systemic inflammation such as sepsis and COVID-19, has major clinical significance to the VA health care system. Recent work from our laboratory demonstrate that an extracellular form of a cytoplasmic intermediate protein circulating in plasma, vimentin, plays important roles in experimental thrombosis, and mediates fibrin polymerization in COVID-19 and in sepsis-induced coagulopathy. This application aims to understand the role of plasma vimentin in thrombosis and fibrin polymerization in systemic inflammation. Our central hypothesis is that plasma vimentin mediates microvascular thrombosis in sepsis and COVID-19 via enhancing thrombin-induced fibrin polymerization. Two aims are proposed: Aim 1 will determine the role of plasma vimentin on microvascular thrombosis in mice and on fibrin polymerization in Veterans with COVID-19- and sepsis-induced coagulopathy. Aim 2 will define the role of post-translational modifications of vimentin and its cell- specific origin on microvascular thrombosis. Completion of the proposed experiments will broaden our understanding of the links between inflammation and microvascular thrombosis in sepsis and COVID-19, and will provide the basis for future work aimed at preventing microvascular thrombosis in systemic inflammation. The long-term goal is to develop optimal therapeutic approaches for patients with sepsis, COVID-19, and other diseases associated with thromboinflammation.
血栓形成和炎症(或血栓炎症)在多种疾病中相互关联 包括败血症或身体对感染的失调反应,以及新型冠状病毒 2019年(COVID-19)。脓毒症通常是最常见的个人入院诊断, VA系统的重症监护病房,尽管在2020年的某些星期,COVID-19 迄今为止,我们的VA医疗中心和其他机构领先的急性内科入院诊断 在VA系统中。尽管重症监护医学取得了进展,但脓毒症和COVID-19仍然存在 作为危及生命的疾病,导致显著的发病率、死亡率和高 全世界退伍军人和非退伍军人的经济负担。COVID-19和败血症都是 与微血管血栓形成和凝血病相关,在这两种情况下, 凝血病的严重程度与死亡率的增加有关。因此,理解 脓毒症等全身性炎症中微血管血栓形成的机制 和COVID-19,对VA医疗保健系统具有重要的临床意义。最近的工作 从我们的实验室证明,细胞质中间蛋白的细胞外形式, 在血浆中循环的波形蛋白在实验性血栓形成中起重要作用, COVID-19和脓毒症诱导的凝血病中的纤维蛋白聚合。本申请旨在 了解血浆波形蛋白在血栓形成和纤维蛋白聚合中的作用, 炎症我们的中心假设是,血浆波形蛋白介导微血管 败血症和COVID-19中的血栓形成通过增强凝血酶诱导的纤维蛋白聚合。 本研究的目的有两个:目的1:研究血浆波形蛋白在微血管形成中的作用。 小鼠血栓形成和退伍军人COVID-19和脓毒症诱导的纤维蛋白聚合 凝血病目的2将明确波形蛋白及其细胞的翻译后修饰的作用, 微血管血栓形成的特异性起源。完成拟议的实验将扩大 我们对脓毒症中炎症和微血管血栓形成之间联系的理解, COVID-19,并将为未来旨在预防微血管的工作提供基础 全身炎症中血栓形成。长期目标是开发最佳治疗方法, 脓毒症、COVID-19和其他与 血栓炎

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROLANDO E RUMBAUT其他文献

ROLANDO E RUMBAUT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROLANDO E RUMBAUT', 18)}}的其他基金

ShEEP request for high-resolution flow cytometry system
ShEEP 请求高分辨率流式细胞术系统
  • 批准号:
    9796556
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
ShEEP Request for Super Resolution Laser Scanning Confocal Microscopy System
ShEEP 请求超分辨率激光扫描共焦显微镜系统
  • 批准号:
    9361137
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Mechanisms of microvascular thrombosis in inflammation
炎症中微血管血栓形成的机制
  • 批准号:
    10382358
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Platelets and microvascular thrombosis in inflammation
炎症中的血小板和微血管血栓形成
  • 批准号:
    9262053
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Mechanisms of microvascular thrombosis in inflammation
炎症中微血管血栓形成的机制
  • 批准号:
    10257657
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
LAMb Request for Laboratory Animal Major Vivarium Equipment
LAMb 请求实验动物主要饲养室设备
  • 批准号:
    9212966
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
The complement system links platelet activation to inflammation
补体系统将血小板激活与炎症联系起来
  • 批准号:
    7793389
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
The complement system links platelet activation to inflammation
补体系统将血小板激活与炎症联系起来
  • 批准号:
    8195599
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
The complement system links platelet activation to inflammation
补体系统将血小板激活与炎症联系起来
  • 批准号:
    8391550
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
The complement system links platelet activation to inflammation
补体系统将血小板激活与炎症联系起来
  • 批准号:
    7907788
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了